Learn more

BAYER ANIMAL HEALTH GMBH

Overview
  • Total Patents
    1,302
  • GoodIP Patent Rank
    2,348
  • Filing trend
    ⇧ 65.0%
About

BAYER ANIMAL HEALTH GMBH has a total of 1,302 patent applications. It increased the IP activity by 65.0%. Its first patent ever was published in 1995. It filed its patents most often in EPO (European Patent Office), Brazil and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are QBiotics Pty Ltd, SANKYO LIFETECH COMPANY LTD and RECORDATI IND CHIMICA E FARMACEUTICA S P A.

Patent filings per year

Chart showing BAYER ANIMAL HEALTH GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Schwarz Hans-Georg 139
#2 Kanikanti Venkata-Rangarao 124
#3 Ilg Thomas 119
#4 Heep Iris 107
#5 Kulke Daniel 88
#6 Turberg Andreas 84
#7 Harder Achim 79
#8 Welz Claudia 76
#9 Griebenow Nils 74
#10 Görgens Ulrich 73

Latest patents

Publication Filing date Title
WO2021069575A1 Heteroaryl-substituted pyrazine derivatives as pesticides
WO2021018839A1 Isoquinoline derivatives and their use for the treatment of parasitic infections
WO2020176887A1 Macrocyclic lactone anthelmintics against nematodes
WO2020161155A1 Holder for active substance strip
WO2021068179A1 Novel heteroaryl-substituted pyrazine derivatives as pesticides
EP3771711A1 Pyrazole derivatives for controlling arthropods
CA3099610A1 New quinoline derivatives
CN111989314A Process for hydrolysis of quinolone formates
EP3712851A1 Reduction of video material to sections with movement
BR112020011901A2 process for preparing anthelmintic derivatives of 4-amino-quinoline-3-carboxamide
AU2018382419A1 Immunostimulatory oligonucleotides
WO2019091975A1 Method for the synthesis of cyclic depsipeptides
EP3643711A1 New anthelmintic compounds
KR20200073216A Use of fused heteroaromatic pyrrolidone for the treatment and prevention of diseases in animals
KR20200044099A Topical dosage forms for the control and prevention of animal parasites
CN111132977A Quinoline derivatives for the treatment of helminth infections
EP3590927A1 Novel compounds for controlling arthropods
CN110770227A Novel azaquinoline derivatives
EP3578182A1 Formulations containing triazinones and iron with a low amount of free iron ions
EP3578181A1 Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies